Caspofungin acetate

Drug ingredient

CAS 179463-17-3

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

US productionNot reported

Import value, 2024$546M

Top sourceItaly 41%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 294190 · basket

These shares come from HS customs code 294190, which covers 90 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IT 41%ItalyCN 24%ChinaDK 9%DenmarkHR 6%CroatiaIN 6%India

United Kingdom
Slovakia
Slovenia
Mexico
Canada
Germany
Belgium
Japan
Switzerland
Netherlands
Czech Republic
Uruguay
South Korea
Hong Kong
Portugal
Australia

14 FDA-registered drug labelers

BrightGene Bio-Medical Technology Co., Ltd.

Chunghwa Chemical Synthesis & Biotech. Ltd

Fosun Pharma USA Inc.

Fresenius Kabi USA, LLC

Gland Pharma Limited

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

HETERO DRUGS LIMITED

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Merck Sharp & Dohme Corp.

Merck Sharp & Dohme LLC

MSN Life Sciences Private Limited

Sagent Pharmaceuticals

Sandoz Inc

Zhejiang Wild Wind Pharmaceutical Co.,Ltd.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

•Cancidas
•Caspofungin Acetate

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

to be discontinued
Caspofungin Acetate Injection
Shortage listed since January 12, 2026

See all current drug shortages

Chemical Identity

CAS179463-17-3

PubChem CID6850808

DTXSIDDTXSID60904590

FormulaC56H96N10O19

Mol. Weight1213.4 g/mol

SMILESCCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O

Data Sources

PubChem · compound 6850808Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Caspofungin acetate (CAS 179463-17-3) https://chemicalindependence.com/chemical/179463-17-3/ PubChem: 6850808. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/6850808 FDA National Drug Code directory: CAS 179463-17-3. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 179463-17-3. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 294190 for CAS 179463-17-3. Reporting year: 2024. https://usatrade.census.gov/